Optimal management of deep infections in orthopedic and trauma surgery is often challenging. Traditional prophylactic and treatment approaches are based on the systemic administration of relatively high doses of antibiotics, which may result in a number of side effects. Furthermore, systemically administered antimicrobials may not reach adequate concentration at the desired site. Finally, traditional approaches are based on two-step protocols, thus delaying definite fixation. In recent years, antibiotic-coated intramedullary nails (ACINs) have been introduced, which offer the advantage of delivering antibiotics locally, thus increasing their local concentrations and length of action. In addition, ACINs offer the great advantage of combining antimicrobial prophylaxis / treatment and stabilization in a single step. Preliminary evidence by small clinical studies appears to support the effectiveness of ACINs in the management of chronic osteomyelitis and infected non-unions, with high rates of infection eradication and bone union. However, randomized clinical trials are needed to definitely establish ACINs' effectiveness and safety.
The incidence of infections in elective orthopedic surgery is generally low, ranging from 0.7 to 4.2% (1). In contrast, in patients with closed fractures the rate of infection is higher, with incidence rates between 3.6 and 8.1% (2) , and reaches 5 to 33% in cases of exposed fractures (3, 4) . Hence, the optimal management of bone fractures requires a careful evaluation of the infectious risk and the adoption of effective countermeasures in cases of actual infections. Indeed, bacteria can adhere to the implant surface, forming a biofilm (glycocalix) that protects them against antimicrobial agents (5) . In addition, within the biofilm, bacteria reduce their metabolic activities, therefore resulting less susceptible to antibiotics (5) . Furthermore, the presence of implants can interfere with the local immune response, especially in polytraumatized patients (6, 7) .
Due to these phenomena, the bacterial load sufficient to initiate an infection is dramatically smaller than it is commonly observed in other circumstances. Moreover, bacterial colonization of metal implants occurs before systemically administered antibiotics can reach local efficacious concentrations. These considerations underline the need for developing new strategies aimed at producing adequate local antibiotic concentrations, in order to reduce the risk of infections and promote the sterilization of the fracture site once a bacterial colonization has occurred.
Over the last decades, intensive research has been devoted to the development of devices able to deliver elevated antibiotic concentrations at the fracture site, avoiding at the same time the risks of adverse events associated with prolonged systemic antibiotic regimens. Examples of local antibiotic delivery systems include polyrnethylmethacrylate (PMMA) bone cement, PMMA beads, collagen sponges, poly-DL-lactide (PDLLA) coated implants, and nails, Kirschner wires and pins coated with PDLLA loaded with antibiotics (8) .
In the following sections, we will present novel approaches to the treatment of infected non-unions and segmental bone defects, able to provide at the same time stability and infection control. Such novel methods are different from traditional 2-step approaches, in which infection control, via debridment, cement beads, systemic antibiotic and provisional stability (mainly through external fixation), is followed by definite fracture stabilization by internal fixation.
METHODS
A MedlinelPubMed database search using "antibiotics coated implants" as search words initially produced 177 citations. The list was then restricted to studies where prophylaxis and treatment of bone infections were performed through antibioticcoated intramedullary nails (ACINs). This selection retrieved 13 citations (6-18) which have been used to define the state of the art about the use of antibiotic-coated intramedullary devices. Six of these studies were performed in laboratory rodents (9) (10) (11) (12) (13) (14) . Among the other publications, one study evaluated the effectiveness of antibacterial prophylaxis of intramedullary nailing in patients with exposed fractures [14] , while 6 papers examined the effectiveness ACINs in the treatment of infected non-unions and ostemyelitis (7, 8, (15) (16) (17) (18) .
RESULTS
For the present review, we selected 4 citations (Table): Thonse and colleagues performed two studies in which they prospectively analyzed the functional outcome in terms of infection control/eradication and bone union of chronic osteomyelitis and infected non-unions by the use of custom-made ACINs. In the first work (8) , an ACIN prepared by mold technique was used, whereas in the second study (9) , the authors compared two distinct ACINs prepared by molding and silicone tubing, respectively. In both studies, internal fixation devices were coated with tobramycin 10% and vancomycin 2.5%. The authors reported a high rate ofinfection eradication (up to 95%),100% bone union rate, and rate ofreintervention or additiorial procedures between 15 and 27%. 
DISCUSSION
Optimal management of deep infections in orthopedic and trauma surgery is often challenging. Indeed, in the recent past, osteomyelitis was synonymous with amputation or death. The introduction of antibiotic (S2) 127 therapy and modern management of orthopedic patients with deep infections have dramatically improved their prognosis, although osteomyelitis is still associated with long in-hospital stay and high rates of reoperations and complications, with subsequent substantial healthcare and societal costs. The cornerstones in the management of orthopedic deep infections are represented by systemic antibiotic therapy, copious irrigation and radical surgical debridement with removal of all necrotic tissues, fracture or infective non-union stabilization, wound closure and soft-tissue coverage. The antibiotic therapy represents a fundamental time in the management of orthopedic infections and its benefits have recently been confirmed by a Cochrane systematic review (20) , which showed that the administration of antibiotics after an open fracture reduces the risk of infection up to 59%.
The site of infection, however, is often characterized by anatomical alterations, with presence of non-viable tissue and compromised blood supply. This impedes the achievement of local optimal doses of antimicrobial agents, which therefore need to be systematically administered in relatively high doses, thus increasing the risk of side effects. The use of local drug-delivery systems offers the advantage of achieving high local antibiotic concentrations, which can be released quickly and for a prolonged time. This increases the bactericidal effect, reducing at the same time the risk of bacterial resistance and systemic side effects. In this respect, the recent introduction of ACINs offers the advantage of a local drug-delivery carrier and a device for definitive fixation of fractures and infective non-unions. Vester et al. (II) analyzed the kinetics of gentamycin release from PDLLA-coated titanium implants in vitro and in vivo. The authors reported that gentamycin was released rapidly in vitro, with over 60% of gentamycin released within the first minute, followed by a slow release. For the in vivo experiment, PDLLNgentamycin-coated Kirschner wires were implanted in the rat tibia. Similar to the in vitro kinetics, gentamycin bone concentration reached a high early peak followed by a decrease to a lower level. No development of resistance was observed, likely as a result of the initial fast release of high doses of gentamycin. Furthermore, the antibacterial efficacy was not affected by the coating process and significantly fewer bacteria were attached to the implant. Finally, osteoblast activity was not affected by gentamycin released from the coating.
A few studies have described the use of ACINs in clinical settings. However, no randomized clinical trials have yet been performed on the topic. The clinical studies presented in this work show a high rate of infection eradication (total rate 87.8%) and bone union (total rate close to 100%), but a high percentage of reintevention or additional procedures (20.9%). No major complications directly attributable to ACINs were reported. These findings are in agreement with the widely acknowledged efficacy of intramedullary nailing in the treatment of long bone fractures, supporting at the same time the effectiveness ofACINs as local drug-delivery carriers. The high rate of reinterventions and the length of management are typical stigmata of the surgery for osteomyelitis. Therefore, these aspects should not be regarded as a device failure. Indeed, in 1932, Kaufmann replaced the word "healing" with the expression "quiescent infection" (21) , and, despite many advances in medicine have been accomplished, biology has not changed since! The present work is limited by the small number of studies published on the topic, the heterogeneity of the devices employed, which are often custom-made, and the observational nature ofthe studies, which makes these works bias-prone and not statistically comparable.
In everydayclinicalpractice,antibioticsare systemically administered for preventing or treating osteomyelitis and implant-relatedinfections in orthopedic and trauma surgery. ACINs may offer the advantage of a prompt release of antimicrobial agents, coupled with the achievement of elevated local concentrations of antibiotics for prolonged period of times. Such an approach may avoid the side effects of systemic therapy, prevent the development of bacterial resistance, and ensure definitive fracture healing in one single step.Although preliminaryclinical data appear to support the use ofACINs, further studies are required to establish their effectivenessand safety.
